[{"id":"f3c142f1-ba9c-4254-9603-796c3a4ecc92","acronym":"","url":"https://clinicaltrials.gov/study/NCT01397929","created_at":"2021-01-18T05:44:35.065Z","updated_at":"2025-02-25T13:33:52.144Z","phase":"Phase 1/2","brief_title":"An Open-Label Study of Intravenous BAL101553 in Adult Patients With Solid Tumors","source_id_and_acronym":"NCT01397929","lead_sponsor":"Basilea Pharmaceutica","biomarkers":" MUC16","pipe":"","alterations":" ","tags":["MUC16"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e lisavanbulin (BAL101553)"],"overall_status":"Completed","enrollment":" Enrollment 73","initiation":"Initiation: 06/01/2011","start_date":" 06/01/2011","primary_txt":" Primary completion: 01/01/2016","primary_completion_date":" 01/01/2016","study_txt":" Completion: 04/01/2016","study_completion_date":" 04/01/2016","last_update_posted":"2023-05-10"}]